Evidence map›Paper›PMID 36932156›Full record

ArticleScientific reports2023

Kinin B

Indiara Brusco, Gabriela Becker, Tais Vidal Palma, Micheli Mainardi Pillat, Rahisa Scussel, Bethina Trevisol Steiner, Tuane Bazanella Sampaio, Daniel Mendes Pereira Ardisson-Araújo, Cinthia Melazzo de Andrade, Mauro Schneider Oliveira and 2 more

Open access · goldFull text read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Kinin BPharmaceutics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Indiara BruscoGraduate Program in Biological Sciences: Biochemistry Toxicology, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Av. Roraima 1000, Camobi, Santa Maria, RS, 97105-900, Brazil. indi_brusco@hotmail.com.
Gabriela BeckerGraduate Program in Biological Sciences: Biochemistry Toxicology, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Av. Roraima 1000, Camobi, Santa Maria, RS, 97105-900, Brazil.
Tais Vidal PalmaGraduate Program in Biological Sciences: Biochemistry Toxicology, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Av. Roraima 1000, Camobi, Santa Maria, RS, 97105-900, Brazil.
Micheli Mainardi PillatDepartment of Microbiology and Parasitology, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Rahisa ScusselGraduate Program in Health Sciences, University of Extreme South Catarinense, Criciuma, SC, Brazil.
Bethina Trevisol SteinerGraduate Program in Health Sciences, University of Extreme South Catarinense, Criciuma, SC, Brazil.
Tuane Bazanella SampaioGraduate Program in Pharmacology, Department of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Daniel Mendes Pereira Ardisson-AraújoGraduate Program in Biological Sciences: Biochemistry Toxicology, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Av. Roraima 1000, Camobi, Santa Maria, RS, 97105-900, Brazil.
Cinthia Melazzo de AndradeGraduate Program in Biological Sciences: Biochemistry Toxicology, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Av. Roraima 1000, Camobi, Santa Maria, RS, 97105-900, Brazil.
Mauro Schneider OliveiraGraduate Program in Pharmacology, Department of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Ricardo Andrez Machado-De-AvilaGraduate Program in Health Sciences, University of Extreme South Catarinense, Criciuma, SC, Brazil.
Sara Marchesan OliveiraGraduate Program in Biological Sciences: Biochemistry Toxicology, Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Av. Roraima 1000, Camobi, Santa Maria, RS, 97105-900, Brazil. saramarchesan@hotmail.com.ORCID 0000-0003-2960-5284
Universidade Federal de Santa Maria · BRUniversidade do Extremo Sul Catarinense · BRUniversidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain caused by the tumor or aromatase inhibitors (AIs) is a disabling symptom in breast cancer survivors. Their mechanisms are unclear, but pro-algesic and inflammatory mediators seem to be involved. Kinins are endogenous algogenic mediators associated with various painful conditions via B

Indexed as

Antineoplastic AgentsCancer PainNeoplasmsAnimalsAromatase InhibitorsBradykininHyperalgesiaMicePaclitaxelPainReceptor, Bradykinin B1Receptor, Bradykinin B2Antineoplastic AgentsAromatase InhibitorsBradykininPaclitaxelReceptor, Bradykinin B1Receptor, Bradykinin B2

Identifiers

PMID36932156
PMCPMC10023805
OpenAlexW4327741896

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read135
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.